Yes. Melinta Therapeutics was formerly owned by 1 private investor.
Melinta Therapeutics is headquartered in Parsippany, New Jersey.
Melinta Therapeutics is a life science company.
389 Interpace Pkwy Suite 450,
Parsippany, New Jersey
07054
United States,
(203) 624-5606
www.melinta.com
Melinta Therapeutics is a molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. Melinta Therapeutics is based in New Haven, Connecticut.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| vol | $270M | $270M | ||||||
| Sell (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| 2 | ||||||||
| Legal | Deals |
|---|---|
|
Willkie Farr & Gallagher |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
